AMI Cardiogenic Shock

Clinical Presentation and In-Hospital Trajectory of Heart Failure and Cardiogenic Shock  

 

In this brief presentation from the Cardiogenic Shock Working Group Global Summit 2023, Jaime Hernandez-Montfort, MD, MPH, MSc, FACC, FHFSA focusses on management of heart failure cardiogenic shock (HF-CS) within the first 12 to 24 hours. He explains that HF-CS is a complex, but actionable, pathophysiologic disease. Patients benefit from early identification and referral to centers for advanced heart failure treatment and recovery. He explains that patients presenting with de novo heart failure had higher in-hospital mortality compared to patients presenting with acute on chronic heart failure, but also were more likely to be discharged with their own heart. He describes refractory cardiogenic shock as a progressive disease and discusses temporary mechanical circulatory support (MCS) options, focusing on evaluation for native heart survival. Dr. Hernandez-Montfort is a member of the Cardiogenic Shock Working Group (CSWG) steering committee.

View more resources

NPS-4131

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].